Literature DB >> 24240600

Incorporation of conjugated linoleic acid isomers into porcine erythrocytes.

Tomaž Malovrh1, Enver Melkić, Drago Kompan, Alenka Levart, Lidija Kompan.   

Abstract

PURPOSE: The aim of the current study was to determine the incorporation of cis (c) 9, trans (t) 11-conjugated linoleic acid (CLA) and t10, c12-CLA into porcine erythrocytes-both isomers were supplemented in equal proportions.
METHODS: The study group consisted of 16 piglets randomly assigned into experimental and control group. For the period of 5 weeks, the piglets from the experimental group were receiving a 1.2% CLA supplement while the controls were supplemented with the same amount of sunflower oil. For the remaining 7 weeks, the piglets were fed without a supplement. Blood samples to evaluate incorporation of CLA into erythrocyte membranes were taken from all animals on weekly basis.
RESULTS: Compared to t10, c12-CLA isomer, proportion of c9, t11-CLA isomer in the membrane of erythrocytes was higher for the whole time of the study period. After 4 weeks of feeding, it approaches the plateau. The peak value for both isomers was measured at the end of week 5, with a value of 3.24 g c9, t11-CLA/100 g of fatty acids and a 1.09 g t10, c12-CLA/100 g of fatty acids (p < 0.0001). After cessation of supplementation, the proportion of both isomers gradually decreased to be almost completely washed out-in 7 weeks.
CONCLUSIONS: During supplementation with equivalent amounts of CLA isomers, their proportion in membranes of porcine erythrocytes increases with time, with higher proportion of c9, t11-CLA. CLA isomers probably differently incorporate into different cell membranes at different species which could explain its various biological functions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24240600     DOI: 10.1007/s00394-013-0618-3

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  8 in total

Review 1.  The biologically active isomers of conjugated linoleic acid.

Authors:  M W Pariza; Y Park; M E Cook
Journal:  Prog Lipid Res       Date:  2001-07       Impact factor: 16.195

2.  Long-term influence of lipid nutrition on the induction of CD8(+) responses to viral or bacterial antigens.

Authors:  J Bassaganya-Riera; R Hontecillas; D R Zimmerman; M J Wannemuehler
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

3.  Effect of CLA supplementation on immune function in young healthy volunteers.

Authors:  H-J Song; I Grant; D Rotondo; I Mohede; N Sattar; S D Heys; K W J Wahle
Journal:  Eur J Clin Nutr       Date:  2005-04       Impact factor: 4.016

4.  Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans.

Authors:  Sabine Tricon; Graham C Burdge; Samantha Kew; Tapati Banerjee; Jennifer J Russell; Robert F Grimble; Christine M Williams; Philip C Calder; Parveen Yaqoob
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

5.  The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects.

Authors:  Enda J Noone; Helen M Roche; Anne P Nugent; Michael J Gibney
Journal:  Br J Nutr       Date:  2002-09       Impact factor: 3.718

Review 6.  Alteration of polyunsaturated fatty acid status and metabolism in health and disease.

Authors:  Nicolas Zamaria
Journal:  Reprod Nutr Dev       Date:  2004 May-Jun

7.  Incorporation of cis-9,trans-11 or trans-10,cis-12 conjugated linoleic acid into plasma and cellular lipids in healthy men.

Authors:  Graham C Burdge; Berit Lupoli; Jennifer J Russell; Sabine Tricon; Samantha Kew; Tapati Banerjee; Kevin J Shingfield; David E Beever; Robert F Grimble; Christine M Williams; Parveen Yaqoob; Philip C Calder
Journal:  J Lipid Res       Date:  2004-02-01       Impact factor: 5.922

Review 8.  Immunomodulatory properties of conjugated linoleic acid.

Authors:  Marianne O'Shea; Josep Bassaganya-Riera; Inge C M Mohede
Journal:  Am J Clin Nutr       Date:  2004-06       Impact factor: 7.045

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.